Compare ZCMD & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZCMD | ACON |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | China | United States |
| Employees | N/A | 11 |
| Industry | Other Consumer Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9M | 8.1M |
| IPO Year | 2019 | N/A |
| Metric | ZCMD | ACON |
|---|---|---|
| Price | $0.11 | $3.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 7.1M | 57.8K |
| Earning Date | 04-28-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $87.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $2.34 |
| 52 Week High | $2.29 | $12.03 |
| Indicator | ZCMD | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 12.24 | 56.38 |
| Support Level | N/A | $3.01 |
| Resistance Level | $0.71 | $3.52 |
| Average True Range (ATR) | 0.25 | 0.16 |
| MACD | -0.16 | 0.01 |
| Stochastic Oscillator | 1.49 | 80.00 |
ZHONGCHAO Inc is an offshore holding company. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provides healthcare information, education, and training services to healthcare professionals under its MDMOOC brand. It also provides focused patient management services through the Zhongxun IT system and WeChat mini program, and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.